Table 7.
Minimal inhibitory concentration of NLCs nanoformulations.
Fungus strain | Minimal inhibitory conc. of each single component and tailored NLCs | ||||||||
---|---|---|---|---|---|---|---|---|---|
α-Terpinene | Carvacrol | Nerolidol | Citronellal | Geraniol | Flu | 1 (NLC-Flu-MTs) | 2 (NLC-MTs) | Cont | |
C. tropicalis | 62.5 ± 2.33 | 62,5 ± 2.45 | 125 ± 8.29 | 31.2 ± 1.98 | 62.5 ± 2.93 | 62.5 ± 2.55 | 0.97 ± 0.09 | 15.6 ± 1.13 | 31.2 ± 2.34 |
C. krusei | NA | 125 ± 7.51 | NA | 125 ± 8.33 | NA | 62.5 ± 3.14 | 31.2 ± 1.32 | 31.2 ± 1.67 | 125 ± 8.02 |
C. glabrata | NA | NA | NA | 125 ± 8.44 | NA | NA | 31.2 ± 2.15 | 62.5 ± 1.95 | 125 ± 6.07 |
G. candidum | 62.5 ± 3.11 | 125 ± 8.77 | 31.2 ± 1.37 | 31.2 ± 2.91 | 125 ± 8.34 | 125 ± 7.98 | 3.9 ± 0.69 | 7.8 ± 0.86 | 31.2 ± 2.17 |
C. albicans | 31.2 | 31.2 | 250 | 62.5 | 62.5 | 125 | 1.9 ± 0.62 | 3.9 ± 0.99 | 31.2 ± 1.89 |
Asp. niger | NA | 125 | 125 | 125 | 125 | NA | 15.6 ± 1.02 | 31.2 ± 1.87 | 62.5 ± 2.66 |
Mucor circinelloide | 31.2 | 62.5 | 125 | 125 | NA | NA | 31.2 ± 1.13 | 62.5 ± 2.94 | 31.2 ± 2.19 |